Xavier Avat, CHIEF BUSINESS OFFICER at CAPRICOR THERAPEUTICS, INC. (CAPR), bought 2,500 shares at $3.76 ($9K) on 2022-06-29, disclosed to the SEC on 2022-07-07.
Open-market purchase of $9k CAPR by CHIEF BUSINESS OFFICER. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history).
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.76 | 1,500 | $6K | 60.5% |
| 2 | $3.68 | 1,000 | $4K | 39.5% |
| Total | $3.73 avg | 2,500 | $9K | 100% |
| Filing → |